Collagen Diseases
Historically, a heterogeneous group of acute and chronic diseases, including rheumatoid arthritis, systemic lupus erythematosus, progressive systemic sclerosis, dermatomyositis, etc. This classification was based on the notion that collagen was equivalent to connective tissue, but with the present recognition of the different types of collagen and the aggregates derived from them as distinct entities, the term collagen diseases now pertains exclusively to those inherited conditions in which the primary defect is at the gene level and affects collagen biosynthesis, post-translational modification, or extracellular processing directly. (From Cecil Textbook of Medicine, 19th ed, p1494)
Subtype terms (6)
More specific conditions that are subtypes of Collagen Diseases in the MeSH hierarchy.
- Ehlers-Danlos Syndrome
10 drugs (7 approved, 3 experimental)
- Epidermolysis Bullosa Dystrophica
23 drugs (6 approved, 17 experimental)
- Keloid
37 drugs (22 approved, 15 experimental)
- Necrobiotic Disorders
- Nephritis, Hereditary
19 drugs (11 approved, 8 experimental)
- Osteogenesis Imperfecta
25 drugs (17 approved, 8 experimental)
Drugs by status
Approved for this indication (2)
Phase 3 trials (2)
Organizations
Organization Involved with Phase 4 Indications (10)
Organization Involved with Phase 3 Indications (11)
Organization Involved with Phase 2 Indications (8)
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (4)